Urinary tract infections in young infants.

Neonatal circumcision revisited. Fetus and Newborn Committee, Canadian Paediatric Society. CMAJ (1996) 2.56

Diagnosis and management of pediatric urinary tract infections. Clin Microbiol Rev (2005) 1.26

Randomised controlled trial of three day versus 10 day intravenous antibiotics in acute pyelonephritis: effect on renal scarring. Arch Dis Child (2001) 1.17

Urinary infection and malformations of urinary tract in infancy. Arch Dis Child (1988) 1.05

First urinary tract infection in neonates, infants and young children: a comparative study. Pediatr Nephrol (2006) 1.01

Comparative prevalence of virulence factors in Escherichia coli causing urinary tract infection in male infants with and without bacteremia. J Clin Microbiol (2006) 0.93

Comparative periurethral bacteriology of uncircumcised and circumcised males. Genitourin Med (1997) 0.93

Six year follow up of infants with bacteriuria on screening. BMJ (1990) 0.89

Emergency Department Septic Screening in Respiratory Syncytial Virus (RSV) and Non-RSV Bronchiolitis. West J Emerg Med (2010) 0.87

The age-related risk of co-existing meningitis in children with urinary tract infection. PLoS One (2011) 0.86

Prevalence of renal anomalies after urinary tract infections in hospitalized infants less than 2 months of age. J Perinatol (2009) 0.82

Urinary tract infection concordance with positive blood and cerebrospinal fluid cultures in the neonatal intensive care unit. J Perinatol (2012) 0.81

Urinary Tract Infection in Boys Less Than Five Years of Age: A General Pediatric Perspective. Kuwait Med J (2006) 0.78

Epidemiology and pharmacoeconomic issues relating to acute respiratory tract infections and acute uncomplicated infections of the urinary tract. Pharmacoeconomics (1994) 0.78

Medical aspects of male circumcision. BMJ (2007) 0.78

Phimosis in children. ISRN Urol (2012) 0.77

Neonates with extra-renal pelvis: the first 2 years. Pediatr Nephrol (2005) 0.76

Care of uncircumcised children. West J Med (1985) 0.75

Office screening for urinary tract infections in infancy. Can Fam Physician (1989) 0.75

Effect of preputial type on bacterial colonization and wound healing in boys undergoing circumcision. Korean J Urol (2012) 0.75

A survey of the management of urinary tract infection in children in primary care and comparison with the NICE guidelines. BMC Fam Pract (2010) 0.75

Visibility of the urethral meatus and risk of urinary tract infections in uncircumcised boys. CMAJ (2012) 0.75

Use of the new pneumococcal conjugate vaccine in the USA. Arch Dis Child (2000) 0.75

The antibiotic susceptibility patterns of uropathogens among children with urinary tract infection in Shiraz. Medicine (Baltimore) (2017) 0.75

Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis. N Engl J Med (1974) 7.89

Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med (1994) 6.92

Epidemiology of Escherichia coli K1 in healthy and diseased newborns. Lancet (1975) 6.25

Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N Engl J Med (1988) 4.17

The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med (1991) 3.94

Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med (1993) 3.67

Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J (1993) 3.38

Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis. J Infect Dis (1981) 3.28

Antibody response of infants to cell surface-exposed outer membrane proteins of Haemophilus influenzae type b after systemic Haemophilus disease. Infect Immun (1982) 3.18

A controlled study of intrathecal antibiotic therapy in gram-negative enteric meningitis of infancy. Report of the neonatal meningitis cooperative study group. J Pediatr (1976) 3.13

Group B streptococci: the new challenge in neonatal infections. J Pediatr (1973) 2.90

A minor high-molecular-weight outer membrane protein of Haemophilus influenzae type b is a protective antigen. Infect Immun (1985) 2.81

The spectrum of group B streptococcal infections in infancy. Am J Dis Child (1974) 2.72

Screening for cephalosporin-resistant Streptococcus pneumoniae with the Kirby-Bauer disk susceptibility test. J Clin Microbiol (1993) 2.69

Relation between Escherichia coli K1 capsular polysaccharide antigen and clinical outcome in neonatal meningitis. Lancet (1974) 2.67

Report of the Task Force on Diagnosis and Management of Meningitis. Pediatrics (1986) 2.62

Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother (1993) 2.61

Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother (1995) 2.50

Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation. J Exp Med (1990) 2.33

Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis. Antimicrob Agents Chemother (1980) 2.27

Sepsis neonatorum. N Engl J Med (1981) 2.27

Cerebrospinal fluid evaluation in neonates: comparison of high-risk infants with and without meningitis. J Pediatr (1976) 2.26

Delayed cerebrospinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children. Pediatrics (1989) 2.23

In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13-9904, and other cephalosporins. Antimicrob Agents Chemother (1980) 2.21

Use of polymerase chain reaction and rabbit infectivity testing to detect Treponema pallidum in amniotic fluid, fetal and neonatal sera, and cerebrospinal fluid. J Clin Microbiol (1991) 2.20

Comparative efficacy of ceftriaxone and cefuroxime for treatment of bacterial meningitis. J Pediatr (1989) 2.17

Gram-negative enteric bacillary meningitis: a twenty-one-year experience. J Pediatr (1993) 2.16

Intraventricular gentamicin therapy in gram-negative bacillary meningitis of infancy. Report of the Second Neonatal Meningitis Cooperative Study Group. Lancet (1980) 2.15

The rate of bacteriologic response to antimicrobial therapy in neonatal meningitis. Am J Dis Child (1972) 2.13

The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro. J Bacteriol (2000) 2.10

Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis. Antimicrob Agents Chemother (1982) 2.08

Conservation of epitopes in the oligosaccharide portion of the lipooligosaccharide of Haemophilus influenzae type b. Infect Immun (1987) 2.06

Sepsis syndrome and septic shock in pediatrics: current concepts of terminology, pathophysiology, and management. J Pediatr (1993) 2.05

Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis 035E. Infect Immun (1998) 2.03

Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications. J Pediatr (1990) 2.01

Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants. J Pediatr (1981) 2.00

Relatively penicillin-resistant pneumococcal infections in pediatric patients. Pediatr Infect Dis (1984) 1.98

A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli. Pediatr Res (1976) 1.96

Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother (1994) 1.96

A protective epitope of Moraxella catarrhalis is encoded by two different genes. Infect Immun (1997) 1.89

A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model. Infect Immun (1993) 1.84

Characterization of the Moraxella catarrhalis uspA1 and uspA2 genes and their encoded products. J Bacteriol (1999) 1.82

Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae. Pediatr Infect Dis J (1999) 1.81

Adverse fetal outcome following maternal rubella after the first trimester of pregnancy. JAMA (1969) 1.78

Single-dose penicillin prophylaxis against neonatal group B streptococcal infections. A controlled trial in 18,738 newborn infants. N Engl J Med (1980) 1.78

Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children. Lancet (1983) 1.77

Clinical pharmacology and efficacy of vancomycin in pediatric patients. J Pediatr (1980) 1.71

Leukocyte function and the development of opsonic and complement activity in the neonate. Am J Dis Child (1971) 1.68

Pharmacological basis for antimicrobial therapy in newborn infants. Am J Dis Child (1974) 1.66

Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis. J Infect Dis (1989) 1.66

Comparative pharmacokinetics of amoxicillin and ampicillin in infants and children. Pediatrics (1979) 1.65

A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis alters serum resistance and survival in vivo. J Infect Dis (1993) 1.63

A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies. J Infect Dis (1994) 1.62

Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis. Antimicrob Agents Chemother (1982) 1.61

Antigenic characterization of the oligosaccharide portion of the lipooligosaccharide of nontypable Haemophilus influenzae. Infect Immun (1987) 1.59

Gentamicin in the neonatal period. Am J Dis Child (1970) 1.59

Correlation of interleukin-1 beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J Pediatr (1989) 1.56

Congenital cytomegalic inclusion disease. A longitudinal study of 20 patients. Am J Dis Child (1969) 1.54

Increasing resistance to trimethoprim-sulfamethoxazole among isolates of Escherichia coli in developing countries. J Infect Dis (1985) 1.54

Consensus: varicella-zoster infections in pregnancy and the perinatal period. Pediatr Infect Dis J (1990) 1.53

Antibiotic pharmacodynamics in cerebrospinal fluid. Clin Infect Dis (1998) 1.52

Diagnosis of enterovirus infection by polymerase chain reaction of multiple specimen types. Pediatr Infect Dis J (1997) 1.52

Changing pattern of the antimicrobial susceptibilities of Escherichia coli in neonatal infections. J Pediatr (1971) 1.51

Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae. J Antimicrob Chemother (1994) 1.51

Infections in children caused by the HB group of bacteria. J Pediatr (1973) 1.49

Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis. J Clin Invest (1989) 1.48

Purulent pericarditis in infancy. Pediatrics (1967) 1.48

Immunoglobulin concentrations in newborn infants with congenital cytomegalic inclusion disease. Pediatrics (1965) 1.47

Pharmacokinetics and bacteriological effect of ceftazidime in experimental Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli meningitis. Antimicrob Agents Chemother (1983) 1.47

Cefprozil concentrations in middle ear fluid of children with acute otitis media. Pediatr Infect Dis J (2000) 1.47

Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. Am J Dis Child (1989) 1.46

Management of atypical mycobacterial lymphadenitis in childhood: a review based on 380 cases. J Pediatr (1979) 1.46

Streptococcal submandibular cellulitis in young infants. Pediatrics (1981) 1.45

Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: a microbiologic, histologic, immunologic, and respiratory plethysmographic profile. Infect Immun (2001) 1.44

Haemophilus influenzae type b lipooligosaccharide induces meningeal inflammation. J Infect Dis (1988) 1.41

Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J (1999) 1.40

Pharmacologic evaluation of orally administered antibiotics in infants and children: effect of feeding on bioavailability. Pediatrics (1978) 1.39

Haemophilus influenzae type b lipooligosaccharide: stability of expression and association with virulence. Infect Immun (1987) 1.38

Haemophilus influenzae type b disease. Incidence in a day-care center. JAMA (1977) 1.37

Cloning and expression in Escherichia coli of the gene encoding the heat-modifiable major outer membrane protein of Haemophilus influenzae type b. Infect Immun (1987) 1.37

Absorption of lindane (gamma benzene hexachloride) in infants and children. J Pediatr (1977) 1.35

CSF shunt infections in pediatrics. A seven-year experience. Am J Dis Child (1984) 1.33

Pulmonary clearance of Moraxella catarrhalis in an animal model. J Infect Dis (1992) 1.32

Expression of the CopB outer membrane protein by Moraxella catarrhalis is regulated by iron and affects iron acquisition from transferrin and lactoferrin. Infect Immun (1996) 1.32

Diagnosis and management of meningitis. Pediatr Infect Dis J (1992) 1.32

Moxalactam therapy for neonatal meningitis due to gram-negative enteric bacilli. A prospective controlled evaluation. JAMA (1984) 1.31

Rapid identification of specific etiology in meningitis. J Pediatr (1976) 1.31

Emergence of rifampin-resistant Haemophilus influenzae after prophylaxis. J Pediatr (1981) 1.31

Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30

Oral antibiotic therapy for skeletal infections of children. II. Therapy of osteomyelitis and suppurative arthritis. J Pediatr (1978) 1.30

Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin. Antimicrob Agents Chemother (1985) 1.29

Cerebrospinal fluid values in the term neonate. Pediatr Infect Dis J (1996) 1.29

Discrepancy between carbenicillin and ampicillin activities against enterococci and Listeria. Antimicrob Agents Chemother (1973) 1.29

Organophosphate and carbamate poisoning in infants and children. Pediatrics (1988) 1.28

Concentrations of antimicrobial agents in middle ear fluid, saliva and tears. Int J Pediatr Otorhinolaryngol (1981) 1.27

Molecular cloning of a gene involved in lipooligosaccharide biosynthesis and virulence expression by Haemophilus influenzae type B. Mol Microbiol (1991) 1.24

Detection of group B streptococcal antigens in body fluids of neonates. J Pediatr (1978) 1.23